These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 28619516)

  • 1. The inner blood-retinal barrier: Cellular basis and development.
    Díaz-Coránguez M; Ramos C; Antonetti DA
    Vision Res; 2017 Oct; 139():123-137. PubMed ID: 28619516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-retinal barrier.
    Cunha-Vaz J; Bernardes R; Lobo C
    Eur J Ophthalmol; 2011; 21 Suppl 6():S3-9. PubMed ID: 23264323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
    Klaassen I; Van Noorden CJ; Schlingemann RO
    Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium.
    Xia T; Rizzolo LJ
    Vision Res; 2017 Oct; 139():72-81. PubMed ID: 28347688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats.
    Barber AJ; Antonetti DA
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5410-6. PubMed ID: 14638745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of vascular permeability in diabetic retinopathy.
    Antonetti DA; Lieth E; Barber AJ; Gardner TW
    Semin Ophthalmol; 1999 Dec; 14(4):240-8. PubMed ID: 10758225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of diabetic macular oedema].
    Krohne TU; Fauser S; Kirchhof B; Joussen AM
    Klin Monbl Augenheilkd; 2003 Aug; 220(8):521-5. PubMed ID: 12953153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt Signaling in Inner Blood-Retinal Barrier Maintenance.
    Yemanyi F; Bora K; Blomfield AK; Wang Z; Chen J
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R; Ohrloff C
    Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats.
    Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
    J Ocul Pharmacol Ther; 1995; 11(3):469-87. PubMed ID: 8590278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
    Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
    Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
    Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
    Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management.
    Kaur C; Foulds WS; Ling EA
    Prog Retin Eye Res; 2008 Nov; 27(6):622-47. PubMed ID: 18940262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy.
    Gardner TW
    Trans Am Ophthalmol Soc; 1995; 93():583-621. PubMed ID: 8719694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cell communication in diabetic retinopathy.
    Roy S; Kim D; Lim R
    Vision Res; 2017 Oct; 139():115-122. PubMed ID: 28583293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The blood-retina barrier and blood-aqueous humor barrier in type I diabetic patients without retinopathy. Determination of permeability using fluorophotometry and laser flare measurements].
    Schalnus R; Ohrloff C
    Klin Monbl Augenheilkd; 1993 Apr; 202(4):281-7. PubMed ID: 8331884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.